These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1019 related articles for article (PubMed ID: 27266853)

  • 41. Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure.
    Trullàs JC; Morales-Rull JL; Casado J; Freitas Ramírez A; Manzano L; Formiga F;
    J Card Fail; 2016 Jul; 22(7):529-36. PubMed ID: 26576715
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure.
    van der Meer P; Postmus D; Ponikowski P; Cleland JG; O'Connor CM; Cotter G; Metra M; Davison BA; Givertz MM; Mansoor GA; Teerlink JR; Massie BM; Hillege HL; Voors AA
    J Am Coll Cardiol; 2013 May; 61(19):1973-81. PubMed ID: 23500313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal effects of added low-dose dopamine in acute heart failure patients with diuretic resistance to natriuretic peptide.
    Kamiya M; Sato N; Nozaki A; Akiya M; Okazaki H; Takahashi Y; Mizuno K; Shimizu W
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):282-8. PubMed ID: 25748698
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implications of Using Different Definitions on Outcomes in Worsening Heart Failure.
    Kelly JP; Cooper LB; Gallup D; Anstrom KJ; Chen HH; Redfield MM; O'Connor CM; Mentz RJ; Hernanadez AF; Felker GM
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27514750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of early diuretic response to carperitide in acute decompensated heart failure treatment: A single-center retrospective study.
    Okuhara Y; Asakura M; Azuma K; Orihara Y; Nishimura K; Ando T; Kondo H; Naito Y; Kashiwase K; Hirotani S; Ishihara M; Masuyama T
    PLoS One; 2018; 13(6):e0199263. PubMed ID: 29912952
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.
    Vaduganathan M; Ambrosy AP; Greene SJ; Mentz RJ; Subacius HP; Maggioni AP; Swedberg K; Nodari S; Zannad F; Konstam MA; Butler J; Gheorghiade M;
    Circ Heart Fail; 2012 Nov; 5(6):750-8. PubMed ID: 23051949
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction.
    Udelson JE; Bilsker M; Hauptman PJ; Sequeira R; Thomas I; O'Brien T; Zimmer C; Orlandi C; Konstam MA
    J Card Fail; 2011 Dec; 17(12):973-81. PubMed ID: 22123358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function.
    Weatherley BD; Cotter G; Dittrich HC; DeLucca P; Mansoor GA; Bloomfield DM; Ponikowski P; O'Connor CM; Metra M; Massie BM;
    J Card Fail; 2010 Jan; 16(1):25-35. PubMed ID: 20123315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction.
    Matsue Y; Ter Maaten JM; Suzuki M; Torii S; Yamaguchi S; Fukamizu S; Ono Y; Fujii H; Kitai T; Nishioka T; Sugi K; Onishi Y; Noda M; Kagiyama N; Satoh Y; Yoshida K; van der Meer P; Damman K; Voors AA; Goldsmith SR
    Clin Res Cardiol; 2017 Oct; 106(10):802-812. PubMed ID: 28540483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy.
    Gottlieb SS; Brater DC; Thomas I; Havranek E; Bourge R; Goldman S; Dyer F; Gomez M; Bennett D; Ticho B; Beckman E; Abraham WT
    Circulation; 2002 Mar; 105(11):1348-53. PubMed ID: 11901047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of low body temperature and poor outcomes in patients admitted with worsening heart failure: a substudy of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) trial.
    Payvar S; Spertus JA; Miller AB; Casscells SW; Pang PS; Zannad F; Swedberg K; Maggioni AP; Reid KJ; Gheorghiade M;
    Eur J Heart Fail; 2013 Dec; 15(12):1382-9. PubMed ID: 23858000
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early administration of tolvaptan preserves renal function in elderly patients with acute decompensated heart failure.
    Kimura K; Momose T; Hasegawa T; Morita T; Misawa T; Motoki H; Izawa A; Ikeda U
    J Cardiol; 2016 May; 67(5):399-405. PubMed ID: 26692119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure.
    Goldsmith SR; Gilbertson DT; Mackedanz SA; Swan SK
    J Card Fail; 2011 Dec; 17(12):982-9. PubMed ID: 22123359
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The development of chronic diuretic resistance can be predicted during a heart-failure hospitalization. Results from the REDIHF registry.
    Blázquez-Bermejo Z; Farré N; Llagostera M; Caravaca Perez P; Morán-Fernández L; Fort A; De-Juan J; Ruiz S; Delgado JF
    PLoS One; 2020; 15(10):e0240098. PubMed ID: 33007024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The top tertile of hematocrit change during hospitalization is associated with lower risk of mortality in acute heart failure patients.
    Zhou H; Xu T; Huang Y; Zhan Q; Huang X; Zeng Q; Xu D
    BMC Cardiovasc Disord; 2017 Sep; 17(1):235. PubMed ID: 28865437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure.
    Rubio-Gracia J; Demissei BG; Ter Maaten JM; Cleland JG; O'Connor CM; Metra M; Ponikowski P; Teerlink JR; Cotter G; Davison BA; Givertz MM; Bloomfield DM; Dittrich H; Damman K; Pérez-Calvo JI; Voors AA
    Int J Cardiol; 2018 May; 258():185-191. PubMed ID: 29544928
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial.
    Gheorghiade M; Gattis WA; O'Connor CM; Adams KF; Elkayam U; Barbagelata A; Ghali JK; Benza RL; McGrew FA; Klapholz M; Ouyang J; Orlandi C;
    JAMA; 2004 Apr; 291(16):1963-71. PubMed ID: 15113814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical benefit of tolvaptan in patients with acute decompensated heart failure and chronic kidney disease.
    Uemura Y; Shibata R; Takemoto K; Uchikawa T; Koyasu M; Ishikawa S; Mitsuda T; Miura A; Imai R; Iwamiya S; Ozaki Y; Kato T; Miura T; Watarai M; Murohara T
    Heart Vessels; 2016 Oct; 31(10):1643-9. PubMed ID: 26615607
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart Failure.
    Segar MW; Khan MS; Patel KV; Butler J; Ravichandran AK; Walsh MN; Willett D; Fonarow GC; Drazner MH; Mentz RJ; Hall J; Farr MA; Hedayati SS; Yancy C; Allen LA; Tang WHW; Pandey A
    JACC Heart Fail; 2024 Mar; 12(3):508-520. PubMed ID: 38099890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
    Mentz RJ; Stevens SR; DeVore AD; Lala A; Vader JM; AbouEzzeddine OF; Khazanie P; Redfield MM; Stevenson LW; O'Connor CM; Goldsmith SR; Bart BA; Anstrom KJ; Hernandez AF; Braunwald E; Felker GM
    JACC Heart Fail; 2015 Feb; 3(2):97-107. PubMed ID: 25543972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.